Structural variants (SVs) are an important source of human genetic diversity, but their contribution to traits, disease and gene regulation remains unclear. We mapped cis expression quantitative trait loci (eQTLs) in 13 tissues via joint analysis of SVs, single-nucleotide variants (SNVs) and short insertion/deletion (indel) variants from deep whole-genome sequencing (WGS). We estimated that SVs are causal at 3.5-6.8% of eQTLs-a substantially higher fraction than prior estimates-and that expression-altering SVs have larger effect sizes than do SNVs and indels. We identified 789 putative causal SVs predicted to directly alter gene expression: most (88.3%) were noncoding variants enriched at enhancers and other regulatory elements, and 52 were linked to genome-wide association study loci. We observed a notable abundance of rare high-impact SVs associated with aberrant expression of nearby genes. These results suggest that comprehensive WGS-based SV analyses will increase the power of common-and rare-variant association studies.
Over the past decade, genome-wide association studies (GWAS) have linked thousands of common genetic variants to human traits and diseases. Fine-mapping of causal variants at GWAS loci has proven difficult because the majority (~88%) of causal variants reside in noncoding genomic regions, and in most cases the causal variants and relevant genes or functional elements are unknown 1 . These challenges have confounded the identification of therapeutic targets for precision medicine. To bridge the gap between molecular and clinical phenotypes, genome-wide eQTL scans have sought to identify genetic determinants of gene expression variation, which serve as markers of functional effects and as bridges connecting germline genetic variation to somatic-cell biology [2] [3] [4] . These studies have successfully identified tens of thousands of eQTLs in a variety of human tissues.
A notable limitation of most eQTL studies is that, owing to their reliance on SNV genotyping arrays, it has been difficult to identify the causal variants underlying eQTL associations and to assess the relative contributions of different variant classes to genetically regulated expression. Of particular interest is structural variation, a broad class of variation that includes copy-number variants (CNVs), balanced rearrangements and mobile-element insertions (MEIs). Structural variation is recognized to be an important source of genetic diversity-5,000 to 10,000 SVs are detectable in a typical human genome through short-read DNA-sequencing technologies-but little is known about the mechanisms through which SVs affect gene expression and phenotypic variation. Although SVs are less abundant than SNVs, which represent ~4 million variant sites per genome 5 , SVs, owing to their size, account for a greater number of nucleotide sequence differences and may therefore exhibit disproportionately large phenotypic effects 6, 7 . Indeed, SVs have been identified as causal contributors to a number of rare and common diseases and are generally presumed to act through their effects on gene expression 8 .
Despite many noteworthy examples linking SVs to gene expression and phenotypic variation in humans, more general and quantitative questions regarding the contribution of SVs relative to other variant classes remain a matter of debate. Several studies have used low-resolution microarray technologies to study the relationship between CNVs and gene expression, but their conclusions have been limited to large CNVs that are now known to compose a small fraction of structural variation [9] [10] [11] [12] . A recent study from the 1000 Genomes Project, the most comprehensive analysis to date, has used RNA-seq expression profiles from lymphoblastoid cell lines (LCLs) of 446 individuals 2 and SVs identified from low-coverage (median 7.4×) WGS data 13 . This analysis has identified 9,591 eQTLs, including 54 with an SV as the lead marker (denoted SV-eQTLs), thus suggesting that SVs are the causal variant at 0.56% of eQTLs. However, the study's shallow sequencing depth limited its SV detection power and genotyping accuracy, both of which are known to be restricted in low-coverage data 7 . Furthermore, although gene expression is differentially regulated across tissues,
Common eQTL mapping
We mapped cis-eQTLs by using 8,980 common SVs with a minorallele frequency (MAF) ≥0.05 and whole-transcriptome RNA-seq data from 13 tissues, including 34,053 expressed genes, 18,126 of which were protein coding (Online Methods and Supplementary Fig. 5 ). We defined an eQTL as an eVariant/eGene pair detected in a given tissue and defined the cis window to include SVs within 1 Mb of each gene transcription start site (TSS). We applied a permutation-based eQTL mapping approach by using FastQTL, identifying 5,128 SV-eQTLs associated with expression differences at 2,064 distinct eGenes and 1,634 distinct eSVs (Benjamini-Hochberg false discovery rate (FDR) of 10%) 19 (Supplementary Table 2 ).
SVs altered exons at 11.0% of eQTLs, thus providing a testable framework to assess their causal effects. Loss-of-function variants such as deletions or exon-disrupting MEIs are expected to decrease gene expression, exon duplications should increase gene expression, and neutral markers that tag a nearby causal variant through linkage disequilibrium (LD) should show bidirectional effects. Indeed, 507/552 (91.8%) of exon-altering eQTLs showed patterns of expression consistent with the SV class (Fig. 2a) . This finding provided strong evidence of a causal role for SVs at a subset of eGenes. In contrast, the remaining 4,566 nonexonic eQTLs (89.0%) generally exhibited bidirectional expression effects (Fig. 2a) , thus possibly reflecting a complex regulatory landscape of both enhancing and repressing DNA elements or loci at which the SV is merely in LD with the true causal variant.
To assess the relative contribution of SV, we expanded our eQTL analysis to include 6,394,161 biallelic SNVs and 801,431 biallelic indels detected with the Genome Analysis Toolkit (GATK) 20 with MAF ≥0.05 (Supplementary Note, Supplementary Fig. 6 and Supplementary  Tables 1 and 3) . We performed joint eQTL mapping with the complete set of genetic variants, nominating a most likely causal variant for each eQTL identified. This process produced 23,554 joint eQTLs across 13 tissues, affecting 9,634 distinct eGenes including 828 SV-eQTLs (3.5%), 20,148 SNV-eQTLs (85.5%) and 2,578 indel-eQTLs (10.9%). The observation that SVs were the lead marker at 3.5% of eQTLs provided an initial estimate of their contribution to gene-expression variation, ranging from 2.4% in transformed fibroblasts to 4.5% in skin (Supplementary Table 4 ). Per-tissue estimates were influenced by the number of available samples for each tissue type, and controlling for the number of available samples recapitulated the relative rates of eQTLs per tissue reported in previous studies 3 (Supplementary Fig. 7 ). SNVs and indels were detected with the Genome Analysis Toolkit (GATK), and SVs were detected on the basis of breakpoint evidence (BP) and supported by read-depth evidence (BP, RD) or detected on the basis of only read-depth evidence (RD). Common variants (MAF ≥0.05) were tested for cis-eQTLs. The SV-only eQTL mapping excluded SNVs and indels for greater sensitivity, whereas the joint eQTL mapping included all variant types.
a Resolution refers to the positional certainty at each breakpoint, and read-depth variants have approximate breakpoint precision on a kilobase scale.
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In whole blood, we observed a nearly fourfold-larger contribution of SVs to protein-coding eQTLs (2.2%) than a similar estimate from the 1000 Genomes Project, in which only 0.56% of eQTLs identified in LCLs had an SV as the lead marker 13 (Supplementary Note and Supplementary Figs. 8-12 ).
Fine-mapping causal variants
We next applied fine-mapping approaches to infer the probability that each locus contained a causal SV in the eGene's cis window. At each of the 23,554 joint eQTLs, we identified the 100 SNVs and indels in the 1-Mb cis window that were most significantly associated with the eGene's expression on the basis of their FastQTL nominal P value, as well as the single most significant SV. We then used the CAVIAR software package to apportion a causal likelihood and a relative ranking to each of these 101 markers on the basis of the magnitude and direction of association as well as the pairwise LD structure across the region 21 . This approach aims to disentangle each variant's causal contribution from its association due to LD with nearby causal markers. At 3.5% of eQTLs overall (2.4-4.4% among tissues), the SV was identified among the 101 candidates as the highest-probability causal variant underlying the eQTL association.
To generate an orthogonal estimate of the SV contribution, we applied a linear mixed model to partition the heritability of each eGene's expression into a fixed effect from the SV and a random effect representing the cumulative heritability of the 1,000 most significant SNVs and indels in the cis region (Fig. 2b,c and Supplementary  Fig. 13 ). This method was similar to approaches used in several prior studies examining the relative contributions of distinct variant classes on a quantitative trait [22] [23] [24] . Heritability partitioning showed that SVs accounted for 8.4% of total gene expression heritability when their effects were summed across all eQTLs, although we note that this analysis included numerous loci where the SV had a very small effect. More importantly, at the 22,448 eQTLs that showed appreciable overall genetic heritability (>0.05), the SV contributed more heritability than the additive effect of the other 1,000 variants in 6.8% of cases, thus suggesting that the SV was the causal variant.
Together, the analyses presented above indicated that SVs were the causal variant at 3.5-6.8% of eQTLs, depending on the causal-variant inference method. These percentages are likely to be underestimates, because the genotyping error rate for SVs is typically higher than that of other variants, thus giving SNVs and indels a relative advantage that makes them likely to 'win' causal-variant prediction tests in regions of strong LD. For example, simulation experiments showed that a 5% increase in SV genotyping error led to a 19.6% decrease in the SV-eQTL mapping rate (Supplementary Fig. 9 ). Although the absolute contribution of SVs to heritable expression variation was small compared with that of SNVs and indels, on a per-variant basis, an SV was 28 to 54 times more likely to modulate expression than an SNV or an indel. Moreover, SVs showed a 1.3-fold-larger median effect size on gene expression than did SNVs and indels (P value <1 × 10 −15 , two-sided Mann-Whitney U test), and deletions showed a 1.4-fold larger median effect size, with the direction of the effect predominantly correlating with SV type (Fig. 2a) . This result was unlikely to stem from differences in statistical power, given the observed allele-frequency distributions of each variant class and that SVs had consistently greater effect sizes across matched allele-frequency bins (Supplementary Fig. 14) . 
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Together, these results demonstrated that SVs play an important and disproportionately large role in defining the landscape of genetically regulated gene expression.
Functional context of eQTLs
We next sought to examine the genomic context of SV-eQTLs for clues regarding their molecular mechanisms. We hypothesized that causal SVs would be enriched in functional elements such as gene bodies, enhancers and repressors. To maximize the number of causal variants in this analysis, we first created an aggregate eQTL set containing the union of all eQTLs identified by either the SV-only or joint eQTL mapping (24,884 eQTLs affecting 10,165 distinct eGenes). We then derived a composite 'causality score' incorporating the aforementioned CAVIAR and GCTA estimates of SV causality at each eQTL, by multiplying the CAVIAR posterior causal probability and the SV's cis heritability fraction (h h cis Fig. 15) . At each eGene, we selected the SV within 1 Mb that had the strongest association with the eGene's expression, and we allocated these 4,398 distinct SVs into six bins according to their composite-score quantile, with the least causal bin composing the bottom half of the composite scores. Different SV classes were represented in approximately consistent proportions across the lower-causality bins, but the most causal bin had higher concentrations of multiallelic CNVs and duplications (Fig. 3a) . SVs in the most causal bin were also enriched in segmental duplications and noncoding gene classes (Supplementary Fig. 16 ), a result consistent with the known concentration of SVs in architecturally complex genomic regions 7, 25 .
We examined the overlap between SVs and annotated genomic features to assess enrichment in various functional elements. SVs in the 90th percentile of causality scores-hereafter referred to as 'predicted causal eSVs'-showed a 23-fold enrichment for altering eGene exons, amounting to 11.7% (92/789) of the predicted causal eSVs, compared with 0.4% of SVs in the least causal bin, representing the lower half of causality scores (Fig. 3b) . Recapitulating the trend from SV-alone eQTL mapping (Fig. 2a) , the expression effect direction was highly correlated with SV type (94/106 showing the expected direction), thus strongly suggesting that this set of exon-altering SVs comprises the causal variants at the respective eQTLs. Importantly, this analysis also demonstrated that our causality score effectively distinguished neutral from causal SVs: little to no enrichment of exon-altering SVs was observed in bins below the 80th percentile of scores, and enrichment steeply rose from the 80th percentile to the 90th percentile.
However, the majority of SVs, including 88.3% of predicted causal eSVs, did not exhibit altered eGene dosage or structure and thus were likely to act through regulatory mechanisms. We analyzed these 4,272 noncoding SVs for enrichment in other functional elements of the genome with potential regulatory consequences. We found that several functional elements were stratified by causality score and were significantly enriched in the most causal bins, including the regions within 1 kb of enhancers, the regions 10 kb upstream or downstream of gene transcripts and the regions predicted by FunSeq to be highly occupied by transcription factors [26] [27] [28] (Fig. 3c-f and Supplementary  Fig. 17 ). In all cases, regulatory-element enrichment was most pronounced in the top causality-score bin-thus providing further evidence of the effectiveness of our scoring method-yet more moderate enrichments were also observed in lower bins.
GWAS-associated SV-eQTLs
To investigate the contribution of SVs to trait-associated loci, we identified 4,874 SNVs from the GWAS catalog that were nonredundant on a per-locus and per-disease basis, were genotyped in the GTEx samples and had convincing evidence of disease association (P < 5 × 10 −8 ) (ref. 29) . Of these, 851 were in LD (r 2 ≥0.5) with a lead marker from our joint SV-SNV-indel eQTL analysis, thus suggesting that the GWAS hit and the eQTL were produced by the same underlying causal variant. An SV was the candidate causal variant at 3.2-14.2% of the 851 GWAS-associated eQTLs, depending on whether causality was judged on the basis of eQTL P-value ranks or heritability partitioning via GCTA (as in the prior causal SV analysis). These results, combined with the eQTL fine-mapping results presented above, suggested that SVs underlie a substantial fraction GWAS-associated eQTLs, thereby indicating that our results are directly relevant to the biology of common diseases.
We next screened for eSVs that were likely to explain prior GWAS results. We identified 52 predicted causal eSVs in LD (r 2 ≥0.5) with GWAS loci, a set showing significant enrichment with functional annotations (Supplementary Table 5 and Fig. 3) . Ultimately, experimental 
A r t i c l e S
validation is required to definitively establish a causal relationship between any given variant and GWAS result. However, there were a number of promising candidates among these 52 loci. In one case, a 294-bp deletion was associated with decreased expression of the DAB2IP gene in thyroid tissue-apparently by disrupting an intronic enhancer-and has been linked to a risk allele for abdominal aortic aneurysm 30 (r 2 = 0.57; Fig. 4a ). In another case, a 1,468-bp deletion in intron 10 of the PADI4 gene was linked (r 2 = 0.70) to a risk allele associated with rheumatoid arthritis 31 (Fig. 4b) . Multiple studies have reported a significant association between haplotypes of the PADI4 gene and rheumatoid arthritis, and PADI4 mRNA is expressed in pathological synovial tissues 32, 33 , yet no studies have implicated this deletion, which flanks an annotated enhancer and has been predicted to be the causal variant for increased PADI4 expression in the lung. Finally, our results identified several SVs previously recognized as clinically associated markers, including an SVA retroelement insertion in a GWAS risk allele for melanoma and esophageal cancer (r 2 = 0.85) [34] [35] [36] , an ~32-kb deletion conferring risk for psoriasis 37 and an ~37-kb deletion linked to circulating liver enzyme levels (gamma-glutamyl transferase) 38 ( Supplementary Fig. 18 ). The extent to which SVs are tagged by other genetic markers via LD is an important consideration in the design of trait-mapping studies. Notably only 58.2% of common autosomal SVs (as well as only 51.4% of predicted causal eSVs) were in strong LD (r 2 ≥0.8) with an SNV or indel ascertained by WGS in our study, compared with 79.4% of common SNVs and 77.6% of eSNVs (by joint eQTL mapping) (Supplementary Note and Supplementary Fig. 19 ). This percentage was markedly lower than a previous estimate that 79% of CNVs detected by microarray analysis were well tagged by nearby markers 39 . Moreover, although modern genotyping arrays are designed to detect large CNVs directly via probe intensity analysis, we found that only 3.8% of common CNVs and 4.9% of eCNVs in our study were detectable by five or more contiguous probes on the Omni 2.5 platform (Supplementary Note and Supplementary Fig. 20) . Indeed, when we omitted SV genotypes from joint eQTL mapping, 41.2% (341/828) of eQTLs originally ascribed to SVs did not meet genome-wide significance through SNV or indel markers (Supplementary Table 6 ).
Effects of rare SVs
We next sought to assess the roles of rare SVs in shaping gene expression variation. In contrast to common variant eQTLs, which are caused by ancient mutations that have been subjected to natural selection, most rare variants arose recently and are more likely to have larger effect sizes and deleterious consequences 40 . Rare variants are difficult to study via traditional eQTL approaches, because any given variant is observed too infrequently within a set of samples to establish a statistically significant relationship with gene expression 41 . However, the effects of rare variants on gene expression can be assessed indirectly via bulk outlier enrichment analyses 42 . We thus identified 5,047 gene expression outliers (median, 30 per person; range, 10-298) in which an individual exhibited aberrant transcript dosage as compared with that in the data set as a whole (Online Methods). Next, we identified 5,660,254 rare variants (4,671 SVs, 4,830,727 SNVs and 824,836 indels) that were positively genotyped in at most two individuals. To decrease the effects of population stratification, we limited this analysis to the 117 individuals of European ancestry with RNA-seq data in at least five tissues.
Rare variants were significantly enriched by 1.2-fold (95% confidence interval (CI), 1.2-1.3) within the gene body and the 5-kb flanking sequence of expression outliers ( Fig. 5a and Supplementary Table 7) . This enrichment was most pronounced for SVs (16.1-fold; 95% CI, 11.5-25.4), in which 355/5,047 (7.0%) of gene expression outliers were in proximity to a rare SV, as compared with the null expectation of 22/5,047 (0.4%) in 1,000 random permutations of the sample expression values. Notably, expression-altering SVs were significantly larger than rare SVs on the whole (P < 1 × 10 −15 , two-sided Mann-Whitney U test), and duplications were disproportionately represented (Fig. 5b,c) . In several cases, a single large SV caused multiple gene expression outliers: a 21.3-Mb duplication event was associated with 161 outliers within the region, and two large duplications (4.1 Mb and 2.5 Mb) were associated with 11 and 30 outliers, respectively. However, the enrichment of rare SVs around outlier genes was not driven by a few large events, because most outlier-associated SVs (56/99) were associated with only a single gene ( Supplementary  Fig. 21 ), nor was this enrichment a consequence of subpopulation structure (Supplementary Note and Supplementary Figs. 22-25) . Moreover, on a per-variant basis, 99/4,671 (2.1%) of the rare SVs had an expression outlier within 5 kb, compared with 10/4,671 (0.2%) in the permutation set, thus representing a 9.9-fold enrichment (95% CI, 5.8-19.8) (Fig. 5a) . These findings demonstrated that rare SVs are enriched in proximity to aberrantly expressed genes, contributing a median of approximately one gene expression outlier per person. We expect this figure to be a large underestimate, given the strict definition of expression outliers used in this study and that rare variants are also likely to contribute to more modest changes in expression.
Our data suggested that rare SVs alter gene expression through diverse mechanisms. Of the 99 rare SVs predicted to causally alter gene expression (permutation-based FDR of 0.2%), 79 (79.8%) were CNVs that changed the dosage of the aberrantly expressed gene (Supplementary Table 8) . Most gene expression changes occurred in the expected direction relative to the dosage alteration (Fig. 5b) , but we observed four deletions and two duplications with expression effects in the opposite direction; all involved partial gene alterations, thus suggesting complex regulatory effects rather than simple dosage compensation. The next most common class (11, 11.1%) comprised noncoding CNVs that appeared to act through regulatory effects and, A r t i c l e S as in the case of the SV-eQTLs (Fig. 2a) , showed bidirectional effects on transcription. Remarkably, we identified a number of atypical SVs with strong yet unpredicted effects on gene expression. These included a 3.6-Mb inversion associated with altered expression of three genes found at or near the breakpoints (one with increased and two with decreased expression); a 391-bp intronic inversion that appeared to cause increased expression; a complex three-breakpoint balanced rearrangement associated with decreased gene expression; and nine complex CNVs involving a combination of multiple copy-number-variable segments and/or adjacent balanced rearrangements, including one highly complex six-breakpoint event resembling chromothripsis (Supplementary Table 9 ). These results were consistent with findings from prior studies describing the prevalence of complex SVs in 'normal' human genomes and provide what is, to our knowledge, the first report on the diversity of gene expression effects caused by rare, complex SVs 13, 43 .
We compared the relative contributions of rare SVs, SNVs and indels with the contributions of expression outliers. Although the overall enrichment in SNVs and indels at gene expression outliers was mild, owing to the high background prevalence of rare variants in these classes, enrichment increased dramatically when analyses were restricted to high-impact mutations (as judged by CADD 44, 45 ; Supplementary Fig. 26 ). Overall, we observed a net excess of 441 outliers within 5 kb of a rare variant in the same individual, as compared with the expected number from permutation tests, or 8.7% (441/5,047) of total outliers. Moreover, by partitioning excess outliers among SVs, SNVs and indels, we estimated that 70.0% of gene expression outliers with a genetic basis could probably be explained by structural variation, whereas merely 16.0% and 13.9% were due to SNVs and indels, respectively (Online Methods and Supplementary Fig. 27 ). Notably, this approximation assumes similar proportions of causal variants for each variant type and hence may underestimate the contribution of SNVs and indels. It also captures only the effects of rare variants within 5 kb of the outlier gene and depends on our definition of expression outliers. Although the strength of the SV effect is due in part to eight very large CNVs (>1 Mb), GTEx individuals should be representative of the general population in terms of the prevalence of large CNVs, and the relative contribution of SVs remained noteworthy even when individuals with megabase-scale CNVs were excluded from the analysis (SV, 40.7%; SNV, 33.5%; indel, 25.9%).
DISCUSSION
Structural variation is an important source of genetic diversity, but assessing its functional consequences has been hindered by technical challenges in detecting and genotyping SVs in large cohorts. Here, we mapped cis-eQTLs from 147 individuals in the GTEx project, in what is, to our knowledge, the first analysis leveraging deep WGS data and multitissue RNA-seq to elucidate the functional role of SVs in a broader genomic context. We estimate that 3.5-6.8% of cis-eQTLs are driven by a causal SV, a several-fold-greater contribution than previously recognized, and we present novel findings demonstrating an disproportionately large role for rare SVs on gene expression outliers.
SV detection and genotyping are known to be challenging endeavors, and results can vary widely, owing to different methodological approaches and sequencing technologies. However, our study improved upon previous SV-eQTL mapping efforts in two ways. First, it harnessed SV genotypes derived directly from deep WGS reads rather than microarrays or haplotype-based genotype refinement of lowcoverage sequencing. Second, it captured the expression profiles of 12 human tissues and transformed fibroblasts rather than a single derived cell line. Using these methods, we observed a nearly fourfold greater contribution of SVs to protein-coding eQTLs than a similar estimate from the 1000 Genomes Project in LCLs 13 , a discrepancy unlikely to stem from trivial methodological differences, given the similarities in eQTL mapping methods used in the two studies. Our analyses of the methodological consequences of genotyping error and haplotype-based refinement suggest that the key difference between these results is the greater sensitivity and accuracy of SV genotypes afforded by deep WGS data, thus underscoring the power and novelty of our study.
Bridging the gap between disease-associated loci and mechanism is a driving motivation for eQTL studies because noncoding variants encompass approximately 88% of GWAS loci 1 , but their gene targets and regulatory effects are often difficult to predict. We applied finemapping approaches to identify 789 putative causal SV-eQTLs. We confirmed previous reports that coding SV-eQTLs generally exhibit an effect direction consistent with SV type 10 , and we observed that noncoding SVs with strong causality predictions were significantly enriched in overlaps with known regulatory elements. Given the paucity of causal variants discovered in the human genome to date, the 789 putatively causal SV-eQTLs identified here-of which 52 are linked (r 2 ≥0.5) with GWAS findings-should serve as a valuable resource for future functional studies.
Finally, we analyzed the functional impact of rare variants, the majority of which are relatively new alleles with limited exposure to purifying selection. Our study assessed bulk enrichment of rare variants in proximity to gene expression outliers, providing what is, A r t i c l e S to our knowledge, the first demonstration that rare SVs are a common cause of aberrantly expressed genes in the human population and that rare SVs contribute a large fraction of gene expression outliers relative to SNVs and indels. This result suggests that thorough ascertainment of SV will significantly increase the power of rare-variant association studies and the efficacy of WGS-based disease diagnosis. An important extension of this work lies in guiding the design of future trait-mapping studies. Our results show that SVs comprise a substantial and disproportionately large fraction of expression-altering genetic variants, a large portion of which have been untested in typical association studies. As human genetics moves deeper into the era of WGS, it will become possible to include all forms of genetic variation in cohort studies and clinical practice. Comprehensive analysis of structural variation will be a critical aspect of these efforts.
ONLINE METhODS
SV call set generation. We acquired 148 deep whole-genome BAM files from the GTEx V6 data release (dbGaP accession phs000424.v6.p1, accessed 11 May 2015). Informed consent for postmortem donors was provided by their next of kin, as described previously 3 . We excluded one sample (GTEX-WHWD-0002) because of an abnormal insert-size distribution, which would confound SV detection. We realigned the remaining 147 whole genomes to GRCh build 37 plus a contig for Epstein-Barr virus by using SpeedSeq v0.0.3 (BWA-MEM v0.7.10-r789) according to previously published methodology 14, 15 . We ran LUMPY v0.2.9 on each sample with the default parameters in the LUMPY Express script, using the published list of excluded genomic regions from SpeedSeq as well as the -P option to output probability curves for each breakpoint 16 . We merged the 147 VCF files by using the l_sort.py and l_merge.py scripts included in LUMPY with the --product option and 20 bp of slop, simultaneously combining variants with overlapping breakpoint intervals while refining their spatial precision on the basis of the probability curves to create a cohort-level VCF. We pruned remaining variants with nearly overlapping breakpoint intervals (within 50 bp) by selecting the single variant with the highest allele frequency among the overlapping set. Next, we genotyped each sample with SVTyper v0.0.3, which performs breakpoint sequencing of pairedend and split-read discordants 14 . We define the term 'allele balance' as the ratio of nonreference to total reads at each breakpoint. Allele balance, a proxy for genotype that is tolerant to inefficiencies in aligning the alternate allele for SVs, was used for most analyses in this paper. We then used CNVnator v0.3 to annotate the copy number of each spanning variant (putative deletions, duplications and inversions).
We applied several filters to the LUMPY call set to flag low-quality SVs. Because 68 samples were sequenced on the Illumina HiSeq 2000 platform, and 79 were sequenced on the Illumina HiSeq X Ten platform, we flagged variants whose linear correlation (r 2 ) between genotype and sequencing platform exceeded 0.1. We further flagged deletions lacking split-read support that were smaller than 418 bp, which was measured to be the empirical minimum deletion size at which all insert-size libraries were able to discriminate between concordant and discordant reads with 95% certainty. We determined that three samples (GTEX-NPJ8-0004, GTEX-T2IS-0002 and GTEX-OIZI-1026) had abnormal read-depth profiles, and we therefore flagged SVs unique to any of those samples, thus effectively excluding them from rare-variant analyses. Finally, we flagged variants with a mean sample quality (MSQ, a measure of genotype quality among positively genotyped samples that is independent of allele frequency) of less than 20 as low quality.
Next, we reclassified variant types, requiring that deletions and duplications exhibit correlation between read depth and the allele balance at the breakpoint. For SVs positively genotyped in at least ten samples, we fit a linear regression and required a slope of at least 1.0 in the appropriate direction (positive for duplications, negative for deletions) and r 2 ≥0.2. For the remaining lowfrequency SVs, we required that >50% of positively genotyped samples have a read depth of >2 median absolute deviation (MAD) (in the correct direction for deletion/duplication) and >0.5 absolute copies from the median of reference genotyped samples. For low-frequency SVs on the sex chromosomes, we limited the above criteria to the sex with more nonreference individuals to avoid sex confounders. We identified mobile-element insertions in the reference genome (rMEIs) as SVs with breakpoint orientations indicative of deletions that had >0.9 reciprocal overlap with an annotated SINE, LINE or SVA element with a sequence divergence of <200 milliDiv, on the basis of RepeatMasker annotations. Owing to the limitations of our pipeline, we were able to detect only mobile elements inserted into the reference genome on the basis of their absence in other genotyped samples.
We ran Genome STRiP 2.00.1602 according to the best-practices workflow for deeply sequenced genomes, using a window size of 1,000 bp, a window overlap of 500 bp, a reference gap length of 1,000 bp, a boundary precision of 100 bp and a minimum refined length of 500 bp. We flagged CNVs for platform bias and the three samples with abnormal coverage profiles, as described above. For rare SVs detected by Genome STRiP (unique or doubletons in our call set) we merged fragmented variants of matching types with identical genotypes within 10 Mb of one another whose combined footprint encompassed at least 10% of their span.
We then unified the LUMPY and Genome STRiP call sets while collapsing redundancies. Because LUMPY variants are substantially more precise and have well-defined confidence intervals, we retained LUMPY calls when an SV was detected by both algorithms with a reciprocal overlap >0.5 and a matching variant type (mCNVs were allowed to merge with either LUMPY duplications or LUMPY deletions). To ensure that SVs would be merged even when the Genome STRiP call was fragmented, as occurs fairly often in GTEx WGS data, we also merged calls in which >0.9 of a Genome STRiP CNV was contained in a LUMPY SV of the same type (or mCNV), and the correlation between LUMPY allele balance and copy number had r 2 >0.25. This last step ensured that the merged variants have a high degree of co-occurrence among samples and are not simply independent variants that inhabit the same genomic interval.
We measured MAF for LUMPY SVs as the ratio of minor alleles to total alleles in the population. For Genome STRiP variants, we defined MAF as the fraction of samples that deviated from the mode copy-number value in the population.
We defined a high-confidence call set from the variants that had not been flagged by the aforementioned filters, were at least 50 bp in size and were located on the autosomes or the X chromosome. In general, high-confidence SVs had to be supported by multiple independent evidence types. Because LUMPY deletions and duplications were identified by paired-end and/or splitread evidence and had also met requisite read-depth support from reclassification, they were automatically considered high confidence. Similarly, rMEIs were considered high confidence on the basis of support from reference-genome repeat annotations. LUMPY inversions and BNDs (unclassified breakends) were required to have a minimum variant-quality score of 100. Inversions were further required to show evidence from both sides of the event, and at least 10% of supporting reads were derived from each of the split-read and paired-end evidence types. LUMPY BND variants were required to have at least 25% of supporting reads derived from each of the split-read and paired-end evidence types. Genome STRiP variants that were merged as described above and those with a GSCNQUAL score ≥10 were considered high confidence. This set of 23,602 variants served as the basis for all analyses in this paper.
We estimated the FDR of this SV call set with Genome STRiP's Intensity Rank Sum (IRS) annotator for in silico CNV validation with Illumina Omni 5M SNV genotyping arrays. Array data were available for 131 of 147 samples, and we used the log(R ratio) (log 2 (R observed /R expected )) of intensity values from Illumina GenomeStudio as IRS input. We tested 7,575 of 17,040 CNVs (deletions or duplications, excluding reference MEIs) that spanned at least one probe.
Array-based CNV calling. For array-based CNV calling used for quality control, DNA samples from each GTEx donor were run on Illumina DNA arrays (n = 186 samples on the Illumina 5M platform, n = 275 samples on the 2.5M platform). GenomeStudio software was used to generate B-allele-frequency and log(R ratio) data for each array experiment, and these normalized probeset summaries were used as the primary data for calling CNVs with plumbCNV, an R package based on the popular and widely used PennCNV algorithm 46,47 . We constructed custom *.pfb files for each array platform by using the full set of GTEx data for each platform. Before CNV calling, we performed sample QC on each array experiment and removed samples with abnormalities in either the mean or variance of the log(R ratio) across the entire genome. Principal component analysis was then used to correct for batch effects in the log(R ratio) data. PennCNV was then used to call CNVs with default parameters. Raw CNV calls were cleaned by (i) merging adjacent CNVs separated by a gap <20% of the size of the smaller CNV and (ii) removing CNVs with >50% overlap with immunoglobulin loci, telomeric and centromeric regions. Post-calling sample QC was performed to identify and remove individuals with an excess of CNV calls on the basis of the Poisson expectation derived from the total set of samples.
Common eQTL mapping. We mapped cis-eQTLs to scan for significant associations between common variant genotypes and gene expression in all tissues for which there were ≥70 individuals with both WGS data and RNA-seq data.
These included the following 12 tissues: whole blood, skeletal muscle, lung, tibial artery, aortic artery, adipose (subcutaneous), thyroid, esophagus mucosa, esophagus muscularis, skin (sun exposed), tibial nerve, muscle (skeletal) and transformed fibroblasts. For convenience, we referred to the transformed fibroblasts as a tissue type throughout this study. Biospecimen collection was performed as previously described 3 . RNA-seq data from each tissue were aligned with TopHat v1.4 with GENCODE v19 gene annotations by taking the union of exons for gene-level quantification, and RPKM values were calculated with RNA-SeQC [48] [49] [50] . Reads were required to align exclusively within exons or to span them (without aligning to intronic regions), align in proper pairs, contain a maximum of six nonreference bases and map uniquely to the gene. Notably, because these gene-level expression values were normalized to the reference transcript length, partial exonic copy-number variants that altered the transcript length were expected to modulate RPKM values even if the absolute number of transcripts remained stable. Samples were quantile normalized within each tissue, then subjected to inverse quantile normalization of each gene to control for outliers.
We selected common genetic markers with MAF ≥0.05 for eQTL mapping. We performed two independent cis-eQTL mapping runs. The first, an SV-only eQTL analysis, used only common SV markers as genotype input for improved sensitivity under a reduced multiple-testing burden. We mapped cis-eQTLs with FastQTL v2.184 by using a cis window of 1 Mb on either side of the TSSs of autosomal and X-chromosome genes with a permutation analysis to identify the most significant marker for each gene 51 . We customized the FastQTL software to include an SV for genotype-expression associations when the span of a deletion, duplication, mCNV or rMEI fell within the cis window for a particular gene TSS or when the breakpoints of an inversion or uncharacterized BND fell within the cis window. For each tissue, we applied a set of covariates including sex, three genotyping principal components, genotyping platform (HiSeq 2000 or HiSeq X Ten) and a variable number of probabilistic estimation of expression residuals (PEER) factors determined on the basis of the number of samples per tissue, N (N < 150, 15 PEERs; 150 ≤ N < 250, 30 PEERs; N ≥ 250, 35 PEERs) 52 . Notably, PEER-factor sample sizes included RNA-seq data from individuals lacking WGS, thus providing more samples for PEER correction than the 147 individuals in the remainder of this study. We performed gene-level multiple-testing correction for each of the SV-only and joint analyses by using the Benjamini-Hochberg method at 10% FDR.
Fine-mapping of causal variants at eQTLs. We used CAVIAR to untangle linkage disequilibrium to predict a causal variant for each eQTL 21 . CAVIAR assesses summary statistics in conjunction with LD across an associated locus to rank the causal probability of each variant in a region. Thus, we ran FastQTL once again on the 24,884 eQTLs that had previously met FDR thresholds in either the SV-only or joint cis-eQTL mapping analyses, to generate the nominal t statistic for every common variant in the cis window. For each eQTL, we selected the most significant SV as well as the 100 most significant SNVs or indels (on the basis of the nominal P value) in the cis window and estimated their pairwise LD with linear regression. For SVs, we used allele balance rather than discrete genotype for computing LD. We ran CAVIAR at each of these eQTLs, by using the t statistics, and signed r values of LD among the 101 variants with a causal set size of 1.
As an alternate estimate of the causal role of structural variation, at each eQTL discovered by either the SV-only or joint analyses, we applied a linear mixed model (LMM) to partition the heritability of each eGene's expression into a fixed effect from the SV and a random effect representing the cumulative heritability of the 1,000 most significant SNVs and indels in the cis region. This method is similar to the methods used in several other studies examining the relative contributions of distinct variant classes to a quantitative trait in n individuals [22] [23] [24] . We first corrected for the same covariates as in the cis-eQTL mapping analyses above by linear regression residualization and then applied a linear model of the form
where  y g is a vector of the normalized expression values, b j g , is the effect of allele dosage of SV j on gene g, x j is an n-length vector of normalized genotypes at SV j,  u g is a n-length vector of random effects drawn from the genetic relatedness matrix (GRM), with
and  e is a random error term drawn
with each feature, allowing 1 kb of flanking distance except for the following: exon-altering plot, no flanking distance; proximity to TSS, 10 kb of directional flanking distance; GENCODE genes, no flanking distance; GENCODE exons, no flanking distance; and topologically associated domain boundaries, 5 kb of flanking distance. SVs involved in multiple eQTLs were considered to touch an eGene if they overlapped the exons of genes at any of those eQTLs. SVs from each causality bin were shuffled with BEDTools into nongapped regions of the genome within 1 Mb of a gene TSS 53 . We calculated the fold enrichment of observed feature intersections compared with the median of 100 random shuffled sets of the elements of each bin to control for each bin's composition of SV types and size distributions. The 95% confidence intervals were derived from the empirical distributions of feature intersections from the shuffled set for each bin. Enhancer positions were defined as those in the Dragon ENhancers database (DENdb) with a minimum support of 2 (ref. 28) (Fig. 3c) . Positions 10 kb upstream and downstream of the TSS were defined on the basis of GENCODE v19 gene positions (Fig. 3d,e) . FunSeq 2.1.0 regions and topologically associated domain boundaries from human embryonic stem cell lines were downloaded from the authors' websites (see URLs) 27, 54 . All other regions were defined by the ENCODE project and downloaded from the UCSC genome browser 26, 55 . eQTL linkage to GWAS hits. We defined a set of phenotype-associated SNVs from the GWAS catalog v1.0.1 (downloaded 4 February 2016) 29 . We selected for results with a P value better than 5 × 10 −8 and tested in Europeans. When multiple markers within a 100-kb window met this criterion in a single study and a single phenotype, we selected the most significant marker in the window to decrease redundancy, thus resulting in a set of 4,951 SNVs, of which 4,874 were genotyped in our cohort of 147 samples. We calculated LD between these GWAS hits and variants in our cohort by using a linear regression to approximate r 2 , using allele balance rather than discrete genotypes for SVs detected with LUMPY.
Rare-variant association with expression outliers. We began by defining gene expression outliers in each of 544 individuals with RNA-seq data across the 44 tissues available from the GTEx project. Because quantile normalization of expression values (as applied in cis-eQTL mapping) can decrease the signal from true expression outliers, we derived PEER-corrected expression values without quantile normalization to define expression outliers. For each tissue, we filtered for genes on the autosomes or the X chromosome in which at least ten individuals had a reads per kilobase of transcript per million mapped reads (RPKM) value >0.1 and raw read count >6. Next we took the log 2 (RPKM + 2) transformation of the data and performed Z transformation across each gene. We then removed PEER factors by linear-regression residualization (using the same number of factors per tissue as described above), then performed Z transformation.
We then subsampled the 544 individuals above to select the 117 who were of European ancestry (because this was the largest subpopulation in our cohort) and had available WGS sequence data. Among these 117 individuals, we identified (sample, gene) pairs at which an individual's absolute median Z score of a gene's expression was at least 2, and there were at least five tissues with available expression data for the gene. This procedure yielded 5,047 gene expression outliers (median, 30 per person; range, 10-298). Next, we identified rare variants that were present in at most two individuals in our cohort of 147 individuals and positively genotyped in at least one of the 117 individuals of European ancestry, thus yielding 5,660,256 rare variants (4,671 SVs, 4,830,727 SNVs and 824,836 indels).
We counted the number of rare SVs, SNVs and indels that co-occurred in the outlier individual and resided within the outlier transcript or 5 kb of flanking sequence. To estimate the probability at which this outcome might occur by chance, we performed 1,000 random permutations of the outlier individual names in our set to determine the number of rare variants of each type that co-occurred with an outlier in a random individual. Notably, this strategy retained the relative number of outliers per individual in each permutation, so that individuals with many outliers were still over-represented in the permuted sets.
We performed two reciprocal measures of enrichments. The 'outlier-centric' approach tested for a significant difference in the number of outliers that had a rare variant within 5 kb (Fig. 5a, red points) . However, for SVs in particular, a single large variant may be in proximity to many outliers, and we controlled for this phenomenon with the 'variant-centric' approach to test for a significant difference in the number of rare variants that had an outlier gene within 5 kb (Fig. 5a, blue points) .
To assess the enrichment across thresholds of variant functional impact, we computed a predicted impact score with CADD v1.2 for all variants in our data set 44 . For SVs, we used the highest-scoring base across the affected interval and the confidence intervals around the SV breakpoints. We then computed the percentiles of these impact scores for SVs, SNVs and indels separately across the full set of allele frequencies. We showed the fold enrichment for the outlier-centric (Supplementary Fig. 26a-c) and variant-centric (Supplementary Fig. 26d-f ) approaches across the range of impact-score percentiles for each variant class.
To estimate the relative contribution of each variant type to expression outliers, we first defined the fraction of outliers with a likely genetic basis. Across 1,000 shuffled permutations of the data, we observed a median of 1,976 outliers (95% CI, 1,917-2,036) with a rare variant of any type in the outlier individual. We identified 2,417 outliers with a rare variant, representing a net excess of 441 over the expected value (95% CI, 381-500). Thus, of the 5,047 total outliers in our data set, an estimated 8.7% (95% CI, 7.6-9.9%) of outliers had a genetic basis.
We then apportioned these 8.7% of genetically determined outliers among SVs, SNVs and indels according to the net excess of observed outliers within 5 kb of each variant type (Supplementary Fig. 27 ). For outliers within 5 kb of multiple variant types (overlaps in the Venn diagram), we allocated the net excess percentage on the basis of the relative strength of their overall fold enrichment. To achieve this, we first estimated the fraction of expression outliers with a genetic basis within each variant type (T SV SNV indel = { , , }) as . ; . in our data set). Then, for each overlapping region in the Venn diagram, we multiplied the net excess by To identify complex variants, we clustered rare SVs with breakpoint evidence located no more than 100 kb away from each other and present in the same individual(s). Rare SVs with only read-depth support were not included in this clustering because of their imprecise boundaries. We joined separate clusters if they contained two sides of the same uncharacterized BND. Clusters containing SVs that had previously been found to be associated with outlier gene expression were reclassified as a complex deletion, complex duplication or balanced complex rearrangement by manual curation. During this manual curation, rare SVs that had only read-depth support and were present in the appropriate sample(s) were added to the rare-variant cluster if they overlapped other variants included in the cluster. After manual inspection, one outlierassociated SV (LUMPY_BND_195398) with inverted breakpoint orientation was visually determined to have amplified read depth over the interval and thus was reclassified as a complex duplication.
Data availability. Sequencing data, and SNV and indel genotypes are available under dbGaP accession code phs000424.v6.p1. The SV call set is available at http://www.gtexportal.org/home/datasets. 
